New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 10, 2014
08:50 EDTKERXKeryx announces submission of MAA for Zerenex to EMA
Keryx Biopharmaceuticals announced it has submitted a Marketing Authorization Application, or MAA, to the European Medicines Agency, or EMA, seeking the approval of Zerenex as a treatment for hyperphosphatemia in patients with chronic kidney disease, or CKD, including dialysis- and non-dialysis dependent CKD. The MAA will be reviewed by the EMA Committee for Medicinal Products for Human Use and the review will be conducted under the Centralized Authorization Procedure. An approval under the Centralized Authorization Procedure provides one marketing authorization which is valid in all 27 member states of the European Union, as well as in Norway, Liechtenstein and Iceland.
News For KERX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 4, 2015
07:48 EDTKERXKeryx announces publication of Auryxia analysis
Subscribe for More Information
March 2, 2015
09:16 EDTKERXKeryx Auryxia outlook still positive, says Roth Capital
Subscribe for More Information
February 27, 2015
09:24 EDTKERXOn The Fly: Pre-market Movers
Subscribe for More Information
08:52 EDTKERXKeryx CFO to leave company by October
Keryx Biopharmaceuticals disclosed in a regulatory filing a planned consolidation of its finance and accounting function into its Boston office and that its CFO, James Oliviero, will be leaving Keryx by October. In connection with this transition, the company entered into an employment agreement with Oliviero that became effective on February 26 and will terminate on October 1, but may be extended upon the mutual agreement of the parties. The company has commenced a search for a new CFO who will be based in its Boston office. Oliviero will continue to manage the company’s finance and accounting team during the remainder of his tenure and will assist in the transition of his duties to the new CFO, Keryx said.
07:14 EDTKERXKeryx reports Q4 EPS (44c), consensus (37c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use